In line with this, our study has shown that in the tumor microenvironment, TGFβRI-induced SMAD3 activates CNS1 enhancer region of FOXP3 genome with concomitant permissive35 chromatin modifications in CD8+ Treg cells. This evidence concerns the gene CD8A and neoplasm.